Malignancies after hematopoietic stem cell transplantation: many questions, some answers

Non-myeloablative versus reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia patients aged ≥65: a study from the ALWP of EBMT.

Bone marrow transplantation·2026

Severe corneal manifestations of graft-versus-host disease: Experience of a tertiary referral center.

The ocular surface·2024

Metabolic syndrome and cardiovascular disease after haematopoietic cell transplantation (HCT) in adults: an EBMT cross-sectional non-interventional study.

Bone marrow transplantation·2021

Postremission Consolidation by Autologous Hematopoietic Cell Transplantation (HCT) for Acute Myeloid Leukemia in First Complete Remission (CR) and Negative Implications for Subsequent Allogeneic HCT in Second CR: A Study by the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT).

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation·2019

Allogeneic hematopoietic stem cell transplantation for patients with relapsed/refractory systemic anaplastic large cell lymphoma. A retrospective analysis of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation.

Bone marrow transplantation·2019

Management of growth failure and growth hormone deficiency after pediatric allogeneic HSCT: Endocrinologists are of importance for further guidelines and studies.

Pediatric hematology and oncology·2019

Vasculopathy in the Forecast: Biophysically Altered Red Cells Act as Hemodynamic Hail to Trigger Endothelial Dysfunction.

Blood·2026

Nipocalimab for warm autoimmune hemolytic anemia: results from the phase 2/3 randomized, double-blind ENERGY study.

Blood·2026

Inhibition of nucleoporin 214 depletes leukemia stem cells by promoting heme catabolism and lipid peroxidation.

Blood·2026

International Consensus Criteria for the Diagnosis, Treatment Initiation, and Response Assessment for T-LGL Leukemia.

Blood·2026

Epigenetic markers expand genetic risk estimation in acute myeloid leukemia.

Blood·2026

Phase 1 Trial with Soquelitinib, a Selective ITK Inhibitor for Treatment of Relapsed/Refractory T Cell Lymphomas.

Blood·2026

Integration of histopathology and molecular features for the classification of benign and malignant hepatocellular neoplasms.

Virchows Archiv : an international journal of pathology·2026

Spatial profiling identifies a distinct and topographically-defined tumor microenvironment that emerges during multiple myeloma evolution.

Blood cancer discovery·2026

Late Recognition of Aromatase Deficiency Following 16 Years of Misdiagnosis as Congenital Adrenal Hyperplasia: A Case with Coexisting Gonadoblastoma and Dysgerminoma.

Journal of clinical research in pediatric endocrinology·2026

Beadex modulates haematopoiesis and innate immune defence against microbial infection in Drosophila melanogaster.

Journal of cell science·2026

Topology and Quality of Life of Cutaneous T-Cell-Lymphomas: A Cross-sectional Study of 153 Patients.

Clinical and experimental dermatology·2026

γδ T cells and cancer.

The Journal of clinical investigation·2026

Related Experiment Videos

Malignancies after hematopoietic stem cell transplantation: many questions, some answers

Related Concept Videos

Non-myeloablative versus reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia patients aged ≥65: a study from the ALWP of EBMT.

Severe corneal manifestations of graft-versus-host disease: Experience of a tertiary referral center.

Metabolic syndrome and cardiovascular disease after haematopoietic cell transplantation (HCT) in adults: an EBMT cross-sectional non-interventional study.

Allogeneic hematopoietic stem cell transplantation for patients with relapsed/refractory systemic anaplastic large cell lymphoma. A retrospective analysis of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation.

Management of growth failure and growth hormone deficiency after pediatric allogeneic HSCT: Endocrinologists are of importance for further guidelines and studies.

Vasculopathy in the Forecast: Biophysically Altered Red Cells Act as Hemodynamic Hail to Trigger Endothelial Dysfunction.

Nipocalimab for warm autoimmune hemolytic anemia: results from the phase 2/3 randomized, double-blind ENERGY study.

Inhibition of nucleoporin 214 depletes leukemia stem cells by promoting heme catabolism and lipid peroxidation.

International Consensus Criteria for the Diagnosis, Treatment Initiation, and Response Assessment for T-LGL Leukemia.

Epigenetic markers expand genetic risk estimation in acute myeloid leukemia.

Phase 1 Trial with Soquelitinib, a Selective ITK Inhibitor for Treatment of Relapsed/Refractory T Cell Lymphomas.

Integration of histopathology and molecular features for the classification of benign and malignant hepatocellular neoplasms.

Spatial profiling identifies a distinct and topographically-defined tumor microenvironment that emerges during multiple myeloma evolution.

Late Recognition of Aromatase Deficiency Following 16 Years of Misdiagnosis as Congenital Adrenal Hyperplasia: A Case with Coexisting Gonadoblastoma and Dysgerminoma.

Beadex modulates haematopoiesis and innate immune defence against microbial infection in Drosophila melanogaster.

Topology and Quality of Life of Cutaneous T-Cell-Lymphomas: A Cross-sectional Study of 153 Patients.

γδ T cells and cancer.

Related Experiment Videos

Malignancies after hematopoietic stem cell transplantation: many questions, some answers

Related Concept Videos

Related Articles